MedCompete Logo

MedCompete for Healthcare Investors

See the competitive landscape before the market reacts. AI-powered intelligence built on structured, continuously updated regulatory and clinical data.

Icon 01
Competitive Benchmarking
AI-powered comparisons across mechanisms of action, endpoints, and clinical outcomes to see where each therapy stands in the competitive landscape.
Icon 02
Clinical & Regulatory Milestones
Explore key milestones across approved drugs and development pipelines using structured FDA, EMA, and clinical trial data.
Icon 03
Cross-Trial Comparison
AI builds comparison tables of efficacy and safety across trials, helping you normalize endpoints and baseline characteristics for true cross-study insight.

How It Works

From Indication to Investment Memo

Choose a medical indication – Select the therapeutic area you want to analyze.

Review the landscape – Explore approved drugs and Phase 1–3 pipeline assets with structured fields including mechanisms of action, endpoints, dosing, safety metrics, populations, and trial designs.

Explore clinical updates – Browse newly published clinical trial results and updates within each competitive landscape.

Generate insights – Use AI-generated summaries and cross-trial comparison tables to support internal diligence and investment memos.

Feature

Built on trusted global healthcare data

All data is source-linked and regularly reviewed.

MedCompete Logo
FDA
EMA
PubMed
ClinicalTrials.gov
NIH
EUDAMED

Used by public market healthcare investors, private biotech funds, venture capital firms, and crossover investors evaluating clinical-stage assets.

Ready to Upgrade Your Investment Process?